Current Methods for Identifying Plasma Membrane Proteins as Cancer Biomarkers

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Plasma membrane proteins are vital biomolecules regulating cellular transport, communication, and immune identity.
• Aberrant expression or mutations in these proteins are linked to various diseases, notably cancer, where they contribute to specific molecular signatures.
• Their surface-exposed domains present opportunities for developing targeted cancer drugs and imaging agents.

Purpose of the Study:

• To review the challenges associated with identifying cancer-related plasma membrane proteins.
• To discuss current methodologies, categorizing them into biased (targeting known proteins) and unbiased (discovering novel proteins) approaches.
• To explore the potential impact of plasma membrane proteins on early cancer detection and treatment strategies.

Main Methods:

• Classification of identification methodologies into biased and unbiased approaches.
• Discussion of techniques used to identify known membrane proteins within cells (biased methods).
• Explanation of methods for discovering unknown membrane proteins without prior assumptions (unbiased methods).

Main Results:

• Identification of significant challenges in pinpointing cancer-specific membrane proteins.
• Detailed overview of existing biased and unbiased methodologies for membrane protein identification.
• Highlighting the critical role of membrane proteins as biomarkers and therapeutic targets in oncology.

Conclusions:

• Overcoming challenges in identifying cancer-related plasma membrane proteins is key for advancing cancer diagnostics and therapeutics.
• Both biased and unbiased methods are essential for a comprehensive understanding of membrane proteomes in cancer.
• Plasma membrane proteins hold significant promise for improving early cancer detection and enabling more effective, targeted treatment strategies.